Prior authorization, step by step

Most GLP-1 prescriptions under Medicare require prior authorization. Here's exactly what that means and how to get to "approved."

Prior authorization (PA) is your plan's way of confirming a medication is medically appropriate before it agrees to cover it. For GLP-1 drugs, the plan typically wants to see your diagnosis, relevant lab values, and sometimes a record of other treatments you've tried. Done right, the process is mostly paperwork your prescriber handles — but knowing the steps helps you avoid delays.

The 5 steps

  1. Your prescriber confirms a qualifying diagnosis. The diagnosis code on the request must match a covered indication.
  2. They submit the PA request to your Part D plan. Usually electronically, with supporting clinical notes.
  3. The plan reviews (typically within 72 hours; 24 hours if expedited). They may approve, deny, or ask for more information.
  4. If approved, you fill at an in-network pharmacy. Your covered copay applies. Approvals are often time-limited and need renewal.
  5. If denied, you appeal. You have the right to a redetermination — see below.

Common reasons PAs get denied

  • Diagnosis doesn't match a covered indication
  • Missing labs (e.g., A1C) or documentation
  • "Step therapy" — plan wants another drug tried first
  • Drug isn't on the plan's formulary
  • Quantity or dose outside plan limits

How to appeal a denial

Medicare gives you a multi-level appeals process. Start with a redetermination request to your plan, usually within 60 days of the denial. Include a letter of medical necessity from your prescriber. If still denied, you can escalate to an independent review.

Source: CMS.gov — Part D coverage determinations & appeals.

Not sure you qualify yet?

Run the free eligibility check first — it'll tell you whether a prior authorization is even worth starting.

Check my eligibility →

Disclaimer: GLP1Bridge.com is an independent informational resource and is not affiliated with, endorsed by, or operated by Medicare, CMS, or any drug manufacturer. This is general education, not medical or legal advice. Timeframes and rules can change — verify with your plan and CMS.gov.